Acral Lentiginous Melanoma
Last Posted: Mar 07, 2023
- Sensitivity and Usefulness of VE1 Immunohistochemical Staining in Acral Melanomas with BRAF Mutation.
Suh Min Song, et al. Annals of dermatology 2021 0 (5) 556-561
- Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival.
Tas Faruk, et al. Pathobiology : journal of immunopathology, molecular and cellular biology 2018 0 (4) 227-231
- Intratumor Heterogeneity of KIT Gene Mutations in Acral Lentiginous Melanoma.
Comodo-Navarro Andréia Neves, et al. The American Journal of dermatopathology 2019 0 (4) 265-271
- Acral Lentiginous Melanomas Harbour Intratumor Heterogeneity in BRAF Exon 15, With Mutations Distinct From V600E/V600K.
Fernandes Mariana, et al. The American Journal of dermatopathology 2019 0 (10) 733-740
- MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project.
Caini Saverio, et al. Melanoma research 2020 0 (5) 500-510
- Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes.
Andrieu Charlotte, et al. Medical sciences (Basel, Switzerland) 2022 0 (2)
- BRAF, C-KIT, and NRAS mutations correlated with different clinicopathological features: an analysis of 691 melanoma patients from a single center.
Ren Min, et al. Annals of translational medicine 2022 0 (2) 31
- Human leukocyte antigen Class II alleles associated with acral lentiginous melanoma in Mexican Mestizo patients: A case-control study.
Roldan-Marin Rodrigo, et al. Indian journal of dermatology, venereology and leprology 2021 12 1-7
- Genetic characteristics and response to systemic therapies of acral lentiginous melanoma at a tertiary care center-a retrospective review.
Jamerson Taylor, et al. Journal of the National Medical Association 2021 9
- 3'UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma.
Tovar-Parra David, et al. In vivo (Athens, Greece) 0 0 (3) 1529-1536
- Mutations in the BRAF, NRAS, and C-KIT Genes of Patients Diagnosed with Melanoma in Colombia Population.
Gutiérrez-Castañeda Luz D, et al. BioMed research international 2020 0 2046947
- BRAF, KIT, and NRAS Mutations of Acral Melanoma in White Patients.
Dika Emi, et al. American journal of clinical pathology 2020 2
- Augmented Decision Making for Acral Lentiginous Melanoma Detection Using Deep Convolutional Neural Networks.
Lee S et al. Journal of the European Academy of Dermatology and Venereology : JEADV 2020 Jan
- BRAF, KIT, NRAS, GNAQ and GNA11 mutation analysis in cutaneous melanomas in Turkish population.
Yilmaz Ismail, et al. Indian journal of pathology & microbiology 0 0 (3) 279-84
- Pathogenetic Implications of BRAF Mutation Distribution in Stage IV Melanoma Patients.
Baiter Mirjam, et al. Dermatology (Basel, Switzerland) 2015 0 (2) 127-33
- Prognostic and Clinicopathologic Associations of BRAF Mutation in Primary Acral Lentiginous Melanoma in Korean Patients: A Preliminary Study.
Hong Jin-Woo, et al. Annals of dermatology 2014 4 (2) 195-202
- KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma.
Zebary A, et al. Journal of dermatological science 2013 8
- Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma.
Puig-Butillé JA, et al. Experimental dermatology 2013 2 (2) 2
- Acral lentiginous melanoma
From NCATS Genetic and Rare Diseases Information Center
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 05, 2023
- Content source: